ENT devices market seen reaching $54.07B by 2030

The Business Research Company says the global ENT devices market rose to $38.75 billion in 2026 and is on track to hit $54.07 billion by 2030, driven by hearing loss, sinus disorders and broader use of advanced diagnostics and implants. Asia-Pacific led the market in 2025, while the company flagged smart devices, outpatient procedures and digital healthcare investment as key growth drivers.

Why it matters: - The ENT devices market is growing as more patients need diagnosis and treatment for ear, nose and throat disorders. - The market size is expected to expand from $35.83 billion in 2025 to $38.75 billion in 2026, then reach $54.07 billion by 2030. - Faster growth in hearing loss care, sinus treatment and outpatient ENT procedures points to rising demand for specialized medical equipment.

What happened: - The Business Research Company released its ENT Devices Market Report 2026, covering market size, trends and a global forecast through 2035. - The report puts 2026 growth at 8.2% year over year. - The report projects a 2026-2030 compound annual growth rate of 8.7%. - The company described ENT devices as tools used to diagnose, treat and manage disorders of the ear, nose and throat. - The report says Asia-Pacific was the largest regional market in 2025. - North America ranked second, and Africa had the smallest regional share.

The details: - Market growth has been driven by higher rates of hearing loss and sinus disorders, more specialty ENT clinics, broader use of diagnostic imaging, an aging population and better access to hearing assessments. - Future growth is expected to come from smart and connected ENT devices, more outpatient procedures, hearing implant advances, digital healthcare investment and earlier diagnosis. - The report expects advanced diagnostic systems, minimally invasive surgical tools, digital hearing assessment devices, implantable hearing solutions and personalized care to shape the forecast period. - ENT devices are used in clinical and hospital settings for hearing assessments, airway management, sinus treatments and surgical interventions. - The report highlights chronic sinusitis, otitis media, hearing loss, sleep apnea and vocal cord disorders as key conditions driving demand. - The World Health Organization said in February 2023 that 430 million people worldwide need rehabilitation for disabling hearing loss, including 432 million adults and 34 million children. - The World Health Organization projects more than 700 million people will have hearing loss by 2050. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The report also includes key technologies and future trend analysis. - A free sample is available here. - The full report is available here.

Between the lines: - The forecast suggests ENT care is shifting toward connected devices, earlier screening and less invasive procedures. - Aging populations and more chronic hearing and sinus conditions are likely to keep equipment demand elevated across both developed and emerging markets. - Asia-Pacific’s lead suggests the strongest near-term opportunity is tied to healthcare expansion and broader access to specialty care in that region.

What's next: - The market is expected to keep compounding through 2030 as clinics and hospitals adopt more digital diagnostics and implantable solutions. - Wider outpatient treatment and improved hearing assessment access could expand the customer base for ENT equipment makers. - The report’s longer-range forecast through 2035 signals continued investor and supplier focus on this segment.